510(k) Report

FDA applicant

Ibl International GmbH

Hamburg, DE1 decision2015–20151 recall

FDA records 1 decision for Ibl International GmbH (Hamburg, DE) in 2015: 1 510(k) clearance. All are in product code NHG (Enzyme Immunoassay, Cortisol, Salivary). Its devices cite 1 predicate, 0 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Ibl International GmbH’s devices, and how often a recall has named them.

FDA decisions per year

1in 2015

2015: 1
2015high 1 (2015) · low 0 (2016)2026

2026 so far, outlined.

Recalls per year

1in 2018

2018: 1
2015high 1 (2018) · low 0 (2015)2026

Class I Class II/III not classified

FIG. 1 — Ibl International GmbH by year, 2015–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Ibl International GmbH’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • NHGEnzyme Immunoassay, Cortisol, Salivary1decision

Whose devices does it build on?

Its devices cite 1 predicate; 0 are its own earlier devices. The firms it cites most:

What has FDA decided for it lately?

  • K150528Cortisol Saliva Luminescence ImmunoassayIbl International GmbH · 20151 recall

The one decision as Ibl International GmbH →

What has been recalled?

1 recall linked to its devices; the latest:

  • K150528Cortisol Saliva Luminescence Immunoassay The IBL International Cortisol Saliva…Jan 12, 2018Class II